These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Familial pseudohyperkalaemia: inhibition of erythrocyte K+ efflux at 4 degrees C by quinine.
    Author: James DR, Stansbie D.
    Journal: Clin Sci (Lond); 1987 Nov; 73(5):557-60. PubMed ID: 3677562.
    Abstract:
    1. Mechanisms responsible for increased erythrocyte K+ efflux in vitro have been investigated in a patient with familial pseudohyperkalaemia. Mean net K+ efflux (4 degrees C) was 108 nmol h-1 10(-9) erythrocytes, seven times greater than the mean for controls (15.2 nmol h-1 10(-9) erythrocytes). Net K+ efflux was not increased at 22 degrees C or 37 degrees C and losses at 4 degrees C were reversed by subsequent incubation at 37 degrees C. 2. Erythrocyte glucose consumption (4 degrees C) was 14 nmol h-1 10(-9) erythrocytes, similar to the mean for controls of 16.8 nmol h-1 10(-9) erythrocytes. This suggests that the increased net K+ efflux (4 degrees C) was not associated with abnormal energy consumption and was therefore unlikely to be due to an abnormality of the Na+, K+-pump. 3. Incubation of erythrocyte suspensions with ouabain (0.1 mmol/1) or frusemide (1 mmol/1) at 4 degrees C or 37 degrees C resulted in no differences in K+ efflux between patient and controls. Incubation with quinine (2 mmol/1), an inhibitor of the erythrocyte Ca2+-dependent K+ channel, reduced net K+ efflux at 4 degrees C, but the effect persisted in Ca2+-depleted erythrocytes, implying that quinine was acting in a non-specific fashion. 4. Chemical pathologists and clinicians must be aware of this condition if inappropriate treatment of pseudohyperkalaemia is to be avoided.
    [Abstract] [Full Text] [Related] [New Search]